Parkinson's and Movement Disorder Institute

Institution (Healthcare)

Homepage ROR

Also Known As

Parkinson's and Movement Disorder Institute · Acronym: PMDI

227

Publications

11.3K

Citations

Authors

120

Concepts

About

Parkinson's and Movement Disorder Institute is a healthcare institution in Long Beach, United States known for medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	38	1.8K
2	Health Sciences	7	12	1.5K
3	Public Health	2	3	41
4	Engineering	1	2	24
5	Natural Sciences	1	4	100

Parkinson's and Movement Disorder Institute

227

Publications

11.3K

Citations

Page 1

	Year	Citations
Neuropathologic substrates of Parkinson disease dementia David J. Irwin, Matthew T. White, Jon B. Toledo, Annals of Neurology	2012	520
Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease Yun‐Cheng Wu, Xinqun Li, Julie Zhu, Neurosignals MitophagyCell DeathOxidative StressCell AutophagyAutophagy	2011	469
Temporal processing in the basal ganglia. Deborah L. Harrington, Kathleen Y. Haaland, Neal Hermanowitz Neuropsychology Basal GangliaBrain MechanismMotor ControlSocial SciencesNeural Mechanism	1998	382
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study Daniel Truong, Drake D. Duane, Joseph Jankovic, Movement Disorders	2005	240
A recommended scale for cognitive screening in clinical trials of Parkinson's disease Kelvin L. Chou, Melissa M. Amick, Jason Brandt, Movement Disorders Neurodegenerative DiseasesNeuropsychological FunctioningPsychiatryCognitive PerformanceMedicine	2010	181
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study) Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser, JAMA Neurology	2017	170
The natural history of embouchure dystonia Steven J. Frucht, Stanley Fahn, Paul Greene, Movement Disorders	2001	170
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia Daniel Truong, Matthew Brodsky, Mark Lew, Parkinsonism & Related Disorders Cervical DystoniaGynecologyLong-term Efficacy	2010	150
Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study) Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser, Movement Disorders	2015	149
Sildenafil citrate (viagra) for the treatment of erectile dysfunction in men with Parkinson's disease Theresa A. Zesiewicz, Mohammed Helal, Robert A. Hauser Movement Disorders Sexual HealthPsychiatryErectile DysfunctionMedicineSildenafil Citrate	2000	118

Page 1